Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The ...
Researchers have built a synthetic-cell platform that can be chemically adjusted in real time, sidestepping a long-standing bottleneck in artificial cell design. The system, based on coacervate ...